 | • レポートコード：D005-00151 • 出版社/出版日：GlobalInfoResearch / 2020年5月29日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、104ページ • 納品方法：Eメール • 産業分類：医療・製薬 |
| Single User | ￥522,000 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥783,000 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥1,044,000 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本調査レポートでは、がん検査/スクリーニングの世界市場を広く調査・分析し、今後の市場展望をまとめております。がん検査/スクリーニングの種類別市場規模（肺がん、血液がん、骨がん、胆嚢がん、その他）、用途別市場規模（病院・診療所、その他）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、企業別販売量と市場シェア、販売チャネルなどの情報を掲載しています。 ・市場概要 ・企業情報（販売量、市場シェア、製品概要、SWOT分析）：Dias Orin、AB SCIEX、Positive Bioscience、Epigenetics、20/20 GeneSystems、Techlab、M Genomics、Genextropy、Abbott Laboratories ・地域別グローバル市場分析 2015年-2020年 ・がん検査/スクリーニングの北米市場（アメリカ、カナダ、メキシコ） ・がん検査/スクリーニングのヨーロッパ市場（ドイツ、イギリス、フランス、ロシア、イタリア） ・がん検査/スクリーニングのアジア市場（中国、日本、韓国、インド、東南アジア、オーストラリア） ・がん検査/スクリーニングの南米市場（ブラジル、アルゼンチン） ・がん検査/スクリーニングの中東・アフリカ市場（サウジアラビア、トルコ、エジプト、南アフリカ） ・種類別分析：肺がん、血液がん、骨がん、胆嚢がん、その他 ・用途別分析：病院・診療所、その他 ・地域別市場規模予測 2021年-2025年 ・販売チャネル、流通業者、代理店 ・調査の結果・結論 |
Market Overview
The global Cancer Testing/Screening market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019.
The Cancer Testing/Screening market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
Market segmentation
Cancer Testing/Screening market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
By Type, Cancer Testing/Screening market has been segmented into:
Lung Cancer
Blood Cancer
Bone Cancer
Gall Bladder Cancer
Others
By Application, Cancer Testing/Screening has been segmented into:
Hospitals and Clinics
Others
Regions and Countries Level Analysis
Regional analysis is another highly comprehensive part of the research and analysis study of the global Cancer Testing/Screening market presented in the report. This section sheds light on the sales growth of different regional and country-level Cancer Testing/Screening markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global Cancer Testing/Screening market.
The report offers in-depth assessment of the growth and other aspects of the Cancer Testing/Screening market in important countries (regions), including:
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia and Australia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Competitive Landscape and Cancer Testing/Screening Market Share Analysis
Cancer Testing/Screening competitive landscape provides details by vendors, including company overview, company total revenue (financials), market potential, global presence, Cancer Testing/Screening sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the Cancer Testing/Screening sales, revenue and market share for each player covered in this report.
The major players covered in Cancer Testing/Screening are:
Dias Orin
AB SCIEX
Positive Bioscience
Epigenetics
20/20 GeneSystems
Techlab
M Genomics
Genextropy
Abbott Laboratories
Table of Contents
1 Cancer Testing/Screening Market Overview
1.1 Product Overview and Scope of Cancer Testing/Screening
1.2 Classification of Cancer Testing/Screening by Type
1.2.1 Global Cancer Testing/Screening Revenue by Type: 2015 VS 2019 VS 2025
1.2.2 Global Cancer Testing/Screening Revenue Market Share by Type in 2019
1.2.3 Lung Cancer
1.2.4 Blood Cancer
1.2.5 Bone Cancer
1.2.6 Gall Bladder Cancer
1.2.7 Others
1.3 Global Cancer Testing/Screening Market by Application
1.3.1 Overview: Global Cancer Testing/Screening Revenue by Application: 2015 VS 2019 VS 2025
1.3.2 Hospitals and Clinics
1.3.3 Others
1.4 Global Cancer Testing/Screening Market by Regions
1.4.1 Global Cancer Testing/Screening Market Size by Regions: 2015 VS 2019 VS 2025
1.4.2 Global Market Size of Cancer Testing/Screening (2015-2025)
1.4.3 North America (USA, Canada and Mexico) Cancer Testing/Screening Status and Prospect (2015-2025)
1.4.4 Europe (Germany, France, UK, Russia and Italy) Cancer Testing/Screening Status and Prospect (2015-2025)
1.4.5 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Cancer Testing/Screening Status and Prospect (2015-2025)
1.4.6 South America (Brazil, Argentina, Colombia) Cancer Testing/Screening Status and Prospect (2015-2025)
1.4.7 Middle East & Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Cancer Testing/Screening Status and Prospect (2015-2025)
2 Company Profiles
2.1 Dias Orin
2.1.1 Dias Orin Details
2.1.2 Dias Orin Major Business and Total Revenue (Financial Highlights) Analysis
2.1.3 Dias Orin SWOT Analysis
2.1.4 Dias Orin Product and Services
2.1.5 Dias Orin Cancer Testing/Screening Revenue, Gross Margin and Market Share (2018-2019)
2.2 AB SCIEX
2.2.1 AB SCIEX Details
2.2.2 AB SCIEX Major Business and Total Revenue (Financial Highlights) Analysis
2.2.3 AB SCIEX SWOT Analysis
2.2.4 AB SCIEX Product and Services
2.2.5 AB SCIEX Cancer Testing/Screening Revenue, Gross Margin and Market Share (2018-2019)
2.3 Positive Bioscience
2.3.1 Positive Bioscience Details
2.3.2 Positive Bioscience Major Business and Total Revenue (Financial Highlights) Analysis
2.3.3 Positive Bioscience SWOT Analysis
2.3.4 Positive Bioscience Product and Services
2.3.5 Positive Bioscience Cancer Testing/Screening Revenue, Gross Margin and Market Share (2018-2019)
2.4 Epigenetics
2.4.1 Epigenetics Details
2.4.2 Epigenetics Major Business and Total Revenue (Financial Highlights) Analysis
2.4.3 Epigenetics SWOT Analysis
2.4.4 Epigenetics Product and Services
2.4.5 Epigenetics Cancer Testing/Screening Revenue, Gross Margin and Market Share (2018-2019)
2.5 20/20 GeneSystems
2.5.1 20/20 GeneSystems Details
2.5.2 20/20 GeneSystems Major Business and Total Revenue (Financial Highlights) Analysis
2.5.3 20/20 GeneSystems SWOT Analysis
2.5.4 20/20 GeneSystems Product and Services
2.5.5 20/20 GeneSystems Cancer Testing/Screening Revenue, Gross Margin and Market Share (2018-2019)
2.6 Techlab
2.6.1 Techlab Details
2.6.2 Techlab Major Business and Total Revenue (Financial Highlights) Analysis
2.6.3 Techlab SWOT Analysis
2.6.4 Techlab Product and Services
2.6.5 Techlab Cancer Testing/Screening Revenue, Gross Margin and Market Share (2018-2019)
2.7 M Genomics
2.7.1 M Genomics Details
2.7.2 M Genomics Major Business and Total Revenue (Financial Highlights) Analysis
2.7.3 M Genomics SWOT Analysis
2.7.4 M Genomics Product and Services
2.7.5 M Genomics Cancer Testing/Screening Revenue, Gross Margin and Market Share (2018-2019)
2.8 Genextropy
2.8.1 Genextropy Details
2.8.2 Genextropy Major Business and Total Revenue (Financial Highlights) Analysis
2.8.3 Genextropy SWOT Analysis
2.8.4 Genextropy Product and Services
2.8.5 Genextropy Cancer Testing/Screening Revenue, Gross Margin and Market Share (2018-2019)
2.9 Abbott Laboratories
2.9.1 Abbott Laboratories Details
2.9.2 Abbott Laboratories Major Business and Total Revenue (Financial Highlights) Analysis
2.9.3 Abbott Laboratories SWOT Analysis
2.9.4 Abbott Laboratories Product and Services
2.9.5 Abbott Laboratories Cancer Testing/Screening Revenue, Gross Margin and Market Share (2018-2019)
3 Market Competition, by Players
3.1 Global Cancer Testing/Screening Revenue and Share by Players (2015-2020)
3.2 Market Concentration Rate
3.2.1 Top 5 Cancer Testing/Screening Players Market Share
3.2.2 Top 10 Cancer Testing/Screening Players Market Share
3.3 Market Competition Trend
4 Market Size by Regions
4.1 Global Cancer Testing/Screening Revenue and Market Share by Regions
4.2 North America Cancer Testing/Screening Revenue and Growth Rate (2015-2020)
4.3 Europe Cancer Testing/Screening Revenue and Growth Rate (2015-2020)
4.4 Asia-Pacific Cancer Testing/Screening Revenue and Growth Rate (2015-2020)
4.5 South America Cancer Testing/Screening Revenue and Growth Rate (2015-2020)
4.6 Middle East & Africa Cancer Testing/Screening Revenue and Growth Rate (2015-2020)
5 North America Cancer Testing/Screening Revenue by Countries
5.1 North America Cancer Testing/Screening Revenue by Countries (2015-2020)
5.2 USA Cancer Testing/Screening Revenue and Growth Rate (2015-2020)
5.3 Canada Cancer Testing/Screening Revenue and Growth Rate (2015-2020)
5.4 Mexico Cancer Testing/Screening Revenue and Growth Rate (2015-2020)
6 Europe Cancer Testing/Screening Revenue by Countries
6.1 Europe Cancer Testing/Screening Revenue by Countries (2015-2020)
6.2 Germany Cancer Testing/Screening Revenue and Growth Rate (2015-2020)
6.3 UK Cancer Testing/Screening Revenue and Growth Rate (2015-2020)
6.4 France Cancer Testing/Screening Revenue and Growth Rate (2015-2020)
6.5 Russia Cancer Testing/Screening Revenue and Growth Rate (2015-2020)
6.6 Italy Cancer Testing/Screening Revenue and Growth Rate (2015-2020)
7 Asia-Pacific Cancer Testing/Screening Revenue by Countries
7.1 Asia-Pacific Cancer Testing/Screening Revenue by Countries (2015-2020)
7.2 China Cancer Testing/Screening Revenue and Growth Rate (2015-2020)
7.3 Japan Cancer Testing/Screening Revenue and Growth Rate (2015-2020)
7.4 Korea Cancer Testing/Screening Revenue and Growth Rate (2015-2020)
7.5 India Cancer Testing/Screening Revenue and Growth Rate (2015-2020)
7.6 Southeast Asia Cancer Testing/Screening Revenue and Growth Rate (2015-2020)
8 South America Cancer Testing/Screening Revenue by Countries
8.1 South America Cancer Testing/Screening Revenue by Countries (2015-2020)
8.2 Brazil Cancer Testing/Screening Revenue and Growth Rate (2015-2020)
8.3 Argentina Cancer Testing/Screening Revenue and Growth Rate (2015-2020)
9 Middle East & Africa Revenue Cancer Testing/Screening by Countries
9.1 Middle East & Africa Cancer Testing/Screening Revenue by Countries (2015-2020)
9.2 Saudi Arabia Cancer Testing/Screening Revenue and Growth Rate (2015-2020)
9.3 UAE Cancer Testing/Screening Revenue and Growth Rate (2015-2020)
9.4 Egypt Cancer Testing/Screening Revenue and Growth Rate (2015-2020)
9.5 South Africa Cancer Testing/Screening Revenue and Growth Rate (2015-2020)
10 Market Size Segment by Type
10.1 Global Cancer Testing/Screening Revenue and Market Share by Type (2015-2020)
10.2 Global Cancer Testing/Screening Market Forecast by Type (2019-2024)
10.3 Lung Cancer Revenue Growth Rate (2015-2025)
10.4 Blood Cancer Revenue Growth Rate (2015-2025)
10.5 Bone Cancer Revenue Growth Rate (2015-2025)
10.6 Gall Bladder Cancer Revenue Growth Rate (2015-2025)
10.7 Others Revenue Growth Rate (2015-2025)
11 Global Cancer Testing/Screening Market Segment by Application
11.1 Global Cancer Testing/Screening Revenue Market Share by Application (2015-2020)
11.2 Cancer Testing/Screening Market Forecast by Application (2019-2024)
11.3 Hospitals and Clinics Revenue Growth (2015-2020)
11.4 Others Revenue Growth (2015-2020)
12 Global Cancer Testing/Screening Market Size Forecast (2021-2025)
12.1 Global Cancer Testing/Screening Market Size Forecast (2021-2025)
12.2 Global Cancer Testing/Screening Market Forecast by Regions (2021-2025)
12.3 North America Cancer Testing/Screening Revenue Market Forecast (2021-2025)
12.4 Europe Cancer Testing/Screening Revenue Market Forecast (2021-2025)
12.5 Asia-Pacific Cancer Testing/Screening Revenue Market Forecast (2021-2025)
12.6 South America Cancer Testing/Screening Revenue Market Forecast (2021-2025)
12.7 Middle East & Africa Cancer Testing/Screening Revenue Market Forecast (2021-2025)
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Data Source
14.3 Disclaimer
14.4 About US
Table 1. Global Cancer Testing/Screening Revenue (USD Million) by Type: 2015 VS 2019 VS 2025
Table 2. Breakdown of Cancer Testing/Screening by Company Type (Tier 1, Tier 2 and Tier 3)
Table 3. Global Cancer Testing/Screening Revenue (USD Million) by Application: 2015 VS 2019 VS 2025
Table 4. Global Market Cancer Testing/Screening Revenue (Million USD) Comparison by Regions 2015-2025
Table 5. Dias Orin Corporate Information, Location and Competitors
Table 6. Dias Orin Cancer Testing/Screening Major Business
Table 7. Dias Orin Cancer Testing/Screening Total Revenue (USD Million) (2017-2018)
Table 8. Dias Orin SWOT Analysis
Table 9. Dias Orin Cancer Testing/Screening Product and Solutions
Table 10. Dias Orin Cancer Testing/Screening Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 11. AB SCIEX Corporate Information, Location and Competitors
Table 12. AB SCIEX Cancer Testing/Screening Major Business
Table 13. AB SCIEX Cancer Testing/Screening Total Revenue (USD Million) (2018-2019)
Table 14. AB SCIEX SWOT Analysis
Table 15. AB SCIEX Cancer Testing/Screening Product and Solutions
Table 16. AB SCIEX Cancer Testing/Screening Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 17. Positive Bioscience Corporate Information, Location and Competitors
Table 18. Positive Bioscience Cancer Testing/Screening Major Business
Table 19. Positive Bioscience Cancer Testing/Screening Total Revenue (USD Million) (2017-2018)
Table 20. Positive Bioscience SWOT Analysis
Table 21. Positive Bioscience Cancer Testing/Screening Product and Solutions
Table 22. Positive Bioscience Cancer Testing/Screening Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 23. Epigenetics Corporate Information, Location and Competitors
Table 24. Epigenetics Cancer Testing/Screening Major Business
Table 25. Epigenetics Cancer Testing/Screening Total Revenue (USD Million) (2017-2018)
Table 26. Epigenetics SWOT Analysis
Table 27. Epigenetics Cancer Testing/Screening Product and Solutions
Table 28. Epigenetics Cancer Testing/Screening Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 29. 20/20 GeneSystems Corporate Information, Location and Competitors
Table 30. 20/20 GeneSystems Cancer Testing/Screening Major Business
Table 31. 20/20 GeneSystems Cancer Testing/Screening Total Revenue (USD Million) (2017-2018)
Table 32. 20/20 GeneSystems SWOT Analysis
Table 33. 20/20 GeneSystems Cancer Testing/Screening Product and Solutions
Table 34. 20/20 GeneSystems Cancer Testing/Screening Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 35. Techlab Corporate Information, Location and Competitors
Table 36. Techlab Cancer Testing/Screening Major Business
Table 37. Techlab Cancer Testing/Screening Total Revenue (USD Million) (2017-2018)
Table 38. Techlab SWOT Analysis
Table 39. Techlab Cancer Testing/Screening Product and Solutions
Table 40. Techlab Cancer Testing/Screening Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 41. M Genomics Corporate Information, Location and Competitors
Table 42. M Genomics Cancer Testing/Screening Major Business
Table 43. M Genomics Cancer Testing/Screening Total Revenue (USD Million) (2017-2018)
Table 44. M Genomics SWOT Analysis
Table 45. M Genomics Cancer Testing/Screening Product and Solutions
Table 46. M Genomics Cancer Testing/Screening Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 47. Genextropy Corporate Information, Location and Competitors
Table 48. Genextropy Cancer Testing/Screening Major Business
Table 49. Genextropy Cancer Testing/Screening Total Revenue (USD Million) (2017-2018)
Table 50. Genextropy SWOT Analysis
Table 51. Genextropy Cancer Testing/Screening Product and Solutions
Table 52. Genextropy Cancer Testing/Screening Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 53. Abbott Laboratories Corporate Information, Location and Competitors
Table 54. Abbott Laboratories Cancer Testing/Screening Major Business
Table 55. Abbott Laboratories Cancer Testing/Screening Total Revenue (USD Million) (2017-2018)
Table 56. Abbott Laboratories SWOT Analysis
Table 57. Abbott Laboratories Cancer Testing/Screening Product and Solutions
Table 58. Abbott Laboratories Cancer Testing/Screening Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 59. Global Cancer Testing/Screening Revenue (Million USD) by Players (2015-2020)
Table 60. Global Cancer Testing/Screening Revenue Share by Players (2015-2020)
Table 61. Global Cancer Testing/Screening Revenue (Million USD) by Regions (2015-2020)
Table 62. Global Cancer Testing/Screening Revenue Market Share by Regions (2015-2020)
Table 63. North America Cancer Testing/Screening Revenue by Countries (2015-2020)
Table 64. North America Cancer Testing/Screening Revenue Market Share by Countries (2015-2020)
Table 65. Europe Cancer Testing/Screening Revenue (Million USD) by Countries (2015-2020)
Table 66. Asia-Pacific Cancer Testing/Screening Revenue (Million USD) by Countries (2015-2020)
Table 67. South America Cancer Testing/Screening Revenue by Countries (2015-2020)
Table 68. South America Cancer Testing/Screening Revenue Market Share by Countries (2015-2020)
Table 69. Middle East and Africa Cancer Testing/Screening Revenue (Million USD) by Countries (2015-2020)
Table 70. Middle East and Africa Cancer Testing/Screening Revenue Market Share by Countries (2015-2020)
Table 71. Global Cancer Testing/Screening Revenue (Million USD) by Type (2015-2020)
Table 72. Global Cancer Testing/Screening Revenue Share by Type (2015-2020)
Table 73. Global Cancer Testing/Screening Revenue Forecast by Type (2021-2025)
Table 74. Global Cancer Testing/Screening Revenue by Application (2015-2020)
Table 75. Global Cancer Testing/Screening Revenue Share by Application (2015-2020)
Table 76. Global Cancer Testing/Screening Revenue Forecast by Application (2021-2025)
Table 77. Global Cancer Testing/Screening Revenue (Million USD) Forecast by Regions (2021-2025)
List of Figures
Figure 1. Cancer Testing/Screening Picture
Figure 2. Global Cancer Testing/Screening Revenue Market Share by Type in 2019
Figure 3. Lung Cancer Picture
Figure 4. Blood Cancer Picture
Figure 5. Bone Cancer Picture
Figure 6. Gall Bladder Cancer Picture
Figure 7. Others Picture
Figure 8. Cancer Testing/Screening Revenue Market Share by Application in 2019
Figure 9. Hospitals and Clinics Picture
Figure 10. Others Picture
Figure 11. Global Cancer Testing/Screening Revenue (USD Million) and Growth Rate (2015-2025)
Figure 12. North America Cancer Testing/Screening Revenue (Million USD) and Growth Rate (2015-2025)
Figure 13. Europe Cancer Testing/Screening Revenue (Million USD) and Growth Rate (2015-2025)
Figure 14. Asia-Pacific Cancer Testing/Screening Revenue (Million USD) and Growth Rate (2015-2025)
Figure 15. South America Cancer Testing/Screening Revenue (Million USD) and Growth Rate (2015-2025)
Figure 16. Middle East and Africa Cancer Testing/Screening Revenue (Million USD) and Growth Rate (2015-2025)
Figure 17. Global Cancer Testing/Screening Revenue (Million USD) and Growth Rate (2015-2025)
Figure 18. Global Cancer Testing/Screening Revenue Share by Players in 2019
Figure 19. Global Top 5 Players Cancer Testing/Screening Revenue Market Share in 2019
Figure 20. Global Top 10 Players Cancer Testing/Screening Revenue Market Share in 2019
Figure 21. Key Players Market Share Trend
Figure 22. Global Cancer Testing/Screening Revenue (Million USD) and Growth Rate (%) (2015-2020)
Figure 23. Global Cancer Testing/Screening Revenue Market Share by Regions (2015-2020)
Figure 24. Global Cancer Testing/Screening Revenue Market Share by Regions in 2018
Figure 25. North America Cancer Testing/Screening Revenue and Growth Rate (2015-2020)
Figure 26. Europe Cancer Testing/Screening Revenue and Growth Rate (2015-2020)
Figure 27. Asia-Pacific Cancer Testing/Screening Revenue and Growth Rate (2015-2020)
Figure 28. South America Cancer Testing/Screening Revenue and Growth Rate (2015-2020)
Figure 29. Middle East and Africa Cancer Testing/Screening Revenue and Growth Rate (2015-2020)
Figure 30. North America Cancer Testing/Screening Revenue Market Share by Countries (2015-2020)
Figure 31. North America Cancer Testing/Screening Revenue Market Share by Countries in 2019
Figure 32. USA Cancer Testing/Screening Revenue and Growth Rate (2015-2020)
Figure 33. Canada Cancer Testing/Screening Revenue and Growth Rate (2015-2020)
Figure 34. Mexico Cancer Testing/Screening Revenue and Growth Rate (2015-2020)
Figure 35. Europe Cancer Testing/Screening Revenue Market Share by Countries (2015-2020)
Figure 36. Europe Cancer Testing/Screening Revenue Market Share by Countries in 2019
Figure 37. Germany Cancer Testing/Screening Revenue and Growth Rate (2015-2020)
Figure 38. UK Cancer Testing/Screening Revenue and Growth Rate (2015-2020)
Figure 39. France Cancer Testing/Screening Revenue and Growth Rate (2015-2020)
Figure 40. Russia Cancer Testing/Screening Revenue and Growth Rate (2015-2020)
Figure 41. Italy Cancer Testing/Screening Revenue and Growth Rate (2015-2020)
Figure 42. Asia-Pacific Cancer Testing/Screening Revenue Market Share by Countries (2015-2020)
Figure 43. Asia-Pacific Cancer Testing/Screening Revenue Market Share by Countries in 2019
Figure 44. China Cancer Testing/Screening Revenue and Growth Rate (2015-2020)
Figure 45. Japan Cancer Testing/Screening Revenue and Growth Rate (2015-2020)
Figure 46. Korea Cancer Testing/Screening Revenue and Growth Rate (2015-2020)
Figure 47. India Cancer Testing/Screening Revenue and Growth Rate (2015-2020)
Figure 48. Southeast Asia Cancer Testing/Screening Revenue and Growth Rate (2015-2020)
Figure 49. South America Cancer Testing/Screening Revenue Market Share by Countries (2015-2020)
Figure 50. South America Cancer Testing/Screening Revenue Market Share by Countries in 2019
Figure 51. Brazil Cancer Testing/Screening Revenue and Growth Rate (2015-2020)
Figure 52. Argentina Cancer Testing/Screening Revenue and Growth Rate (2015-2020)
Figure 53. Middle East and Africa Cancer Testing/Screening Revenue Market Share by Countries (2015-2020)
Figure 54. Middle East and Africa Cancer Testing/Screening Revenue Market Share by Countries in 2019
Figure 55. Saudi Arabia Cancer Testing/Screening Revenue and Growth Rate (2015-2020)
Figure 56. UAE Cancer Testing/Screening Revenue and Growth Rate (2015-2020)
Figure 57. Egypt Cancer Testing/Screening Revenue and Growth Rate (2015-2020)
Figure 58. South Africa Cancer Testing/Screening Revenue and Growth Rate (2015-2020)
Figure 59. Global Cancer Testing/Screening Revenue Share by Type (2015-2020)
Figure 60. Global Cancer Testing/Screening Revenue Share by Type in 2019
Figure 61. Global Cancer Testing/Screening Market Share Forecast by Type (2021-2025)
Figure 62. Global Lung Cancer Revenue Growth Rate (2015-2020)
Figure 63. Global Blood Cancer Revenue Growth Rate (2015-2020)
Figure 64. Global Bone Cancer Revenue Growth Rate (2015-2020)
Figure 65. Global Gall Bladder Cancer Revenue Growth Rate (2015-2020)
Figure 66. Global Others Revenue Growth Rate (2015-2020)
Figure 67. Global Cancer Testing/Screening Revenue Share by Application (2015-2020)
Figure 68. Global Cancer Testing/Screening Revenue Share by Application in 2019
Figure 69. Global Cancer Testing/Screening Market Share Forecast by Application (2021-2025)
Figure 70. Global Hospitals and Clinics Revenue Growth Rate (2015-2020)
Figure 71. Global Others Revenue Growth Rate (2015-2020)
Figure 72. Global Cancer Testing/Screening Revenue (Million USD) and Growth Rate Forecast (2021-2025)
Figure 73. Global Cancer Testing/Screening Revenue (Million USD) Forecast by Regions (2021-2025)
Figure 74. Global Cancer Testing/Screening Revenue Market Share Forecast by Regions (2021-2025)
Figure 75. North America Cancer Testing/Screening Revenue Market Forecast (2021-2025)
Figure 76. Europe Cancer Testing/Screening Revenue Market Forecast (2021-2025)
Figure 77. Asia-Pacific Cancer Testing/Screening Revenue Market Forecast (2021-2025)
Figure 78. South America Cancer Testing/Screening Revenue Market Forecast (2021-2025)
Figure 79. Middle East and Africa Cancer Testing/Screening Revenue Market Forecast (2021-2025)
Figure 80. Sales Channel: Direct Channel vs Indirect Channel
乳がん検診の世界市場 2020年：メーカー別、地域別、種類・用途別 Summary Market Overview The global Breast Cancer Screening market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of 8.0% in the forecast period of 2020 to 2025 and will expected to reach USD 2352.1 million by 2025, from USD 1726.4 million in 2019. The Brea…- 甲状腺がん検査の世界市場 2020年：企業別、地域別、種類・用途別 Market Overview The global Thyroid Cancer Testing market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Thyroid Cancer Testing…
- AFPテストの世界市場 2020年：企業別、地域別、種類・用途別 Market Overview The global AFP Testing market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The AFP Testing market report provide…
- 膀胱がん治療・診断の世界市場 2020年：企業別、地域別、種類・用途別 Market Overview The global Bladder Cancer Therapeutics and Diagnostics market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of 6.6% in the forecast period of 2020 to 2025 and will expected to reach USD 551.5 million by 2025, from USD 427.6 million in 2019…
- 白血病スクリーニングの世界市場 2020年：企業別、地域別、種類・用途別 Market Overview The global Leukemia Screening market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Leukemia Screening market …